2don MSN
Oral or transdermal hormone therapy? The mental health risks are not the same, study suggests
Hormone therapy–oral and transdermal–remains the most effective treatment for such bothersome menopause symptoms as hot ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
A 24-hour continuous subcutaneous infusion of foslevodopa/foscarbidopa improved Parkinson's disease (PD) motor symptoms during all waking hours for patients with ...
A panelist discusses how oral combination therapy with decitabine-cedazuridine plus venetoclax shows activity in the relapsed/refractory acute myeloid leukemia setting, achieving responses even in ...
News-Medical.Net on MSN
Oral targeted therapy shrinks tumors in over 70% of patients with HER2-mutant NSCLC
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback